Antibodies safeguard us against infection, but hinder life-saving treatments like gene therapies and organ transplants. Until now, we’ve lacked the means to control antibodies when they stand in the way of critical medical interventions.
We’re changing that. Our breakthrough technology offers the first-ever solution to instantly block all harmful antibody responses, unlocking the full potential of cutting-edge treatments for patients with rare diseases.